Patient-Derived Organoids as a Platform to Decipher and Overcome Radioresistance: From the Tumor Microenvironment to Radiosensitizer Discovery.
Yin D, Hong X, Wang X, Ding W, Wang C, Qian J, Zhou Y, Sun C, Wu Z.
Curr Oncol. 2025 Dec 1;32(12):680. doi: 10.3390/curroncol32120680.
PMID:41440207
Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor.
Lee YE, Choi SA, Kwack PA, Kim HJ, Kim IH, Wang KC, Phi JH, Lee JY, Chong S, Park SH, Park KD, Hwang DW, Joo KM, Kim SK.
Neuro Oncol. 2017 Aug 1;19(8):1079-1087. doi: 10.1093/neuonc/now300.
PMID:28340172
Triggered radiosensitizer delivery using thermosensitive liposomes and hyperthermia improves efficacy of radiotherapy: An in vitro proof of concept study.
Besse HC, Bos C, Zandvliet MMJM, van der Wurff-Jacobs K, Moonen CTW, Deckers R.